Abstract
Introduction. Over the past few decades, the incidence of pancreatic cancer has dramatically increased worldwide. Despite the high prevalence of this oncological pathology, there is currently no consensus on the expediency of performing radical reconstructive-plastic surgeries in case of malignant pancreatic tumors.
 Aim: to study the influence of reconstructive-plastic techniques of surgical treatment of pancreatic cancer on the life expectancy of patients and its quality.
 Materials and methods. Analysis of the short and long-term outcomes of surgical treatment of pancreatic cancer was conducted. In total, radical operative interventions were carried out in 32 patients, including 14 men (56.25%) and 18 women (43,75%), aged 37 to 72 (61,5±10,0) years. Pyloro-preserving pancreatoduodenal resection was performed in 20 (62.5%) patients, gastropancreatoduodenal resection — in 6 (18.8%) patients, proximal resection — in 5 (15.6%) patients, distal pancreatic resection — in 1 case (3,1%). Areflux pancreatojejunal anastomosis was formed in patients by the clinic technique.
 Results. Hospital mortality was 6.25%. More than three years after surgery, 15.6% of patients are alive; the median survival rate is 19.5±2.4 months. An assessment of the quality of life and the function of the formed pancreatojejunostomy conducted in the immediate and remote periods showed that the presence of areflux valve reliably prevents the development of pancreatic stump, providing a high level of quality of life for patients.
 Conclusions. The use of organ-preserving and organ-modulating techniques in the treatment of operable pancreatic cancer does not affect survival, but provides an acceptable level of quality of life for patients in the short and long-term perspective after surgery.
Highlights
Over the past few decades, the incidence of pancreatic cancer has dramatically increased worldwide
Areflux pancreatojejunal anastomosis was formed in patients by the clinic technique
remote periods showed that the presence of areflux valve reliably prevents the development
Summary
Методика формирования панкреатоеюноанасто моза была описана нами ранее [1]. На рис. 1 пред ставлена принципиальная схема арефлюксного панк реатоеюноанастомоза. У 21 пациента (65,6%) были выявлены лимфоген ные метастазы При III стадии все пациенты имели метастазы в лимфатических узлах. Основным способом оперативного лечения (32% случаев) была панкреатодуоденальная резек ция (ПДР) До операции все пациенты проходили комплекс ное стационарное обследование, включающее об щеклинические, лабораторные и инструментальные методы исследования. При опросе выявляли жалобы на наличие или от сутствие пожелтения кожных покровов и склер, боли характерной локализации, потемнение мочи, изме нение цвета каловых масс, потерю массы тела, об щую слабость. Жерлова были разработаны и применя ются способы ПДР с формированием арефлюксно го панкреатоеюноанастомоза. 1. Схема арефлюксного панкреатоеюноанастомоза по методике Г. В ближайшие и отдаленные сроки после опера ции все пациенты проходили комплексное стацио нарное обследование, которое включало клиниче ские, лабораторные и инструментальные методики, направленные на оценку морфофункционального состояния сформированного арефлюксного меха низма и качества жизни. Таблица 3 Распределение больных в зависимости от наличия метастатического поражения
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
